Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
KONSUL'TANT GLP-PLANET 2023. MNENIE FARMACEVTIChESKOJ OTRASLI
View through CrossRef
В монографии «Консультант GLP-PLANET. Мнение фармацевтической отрасли» приводятся представления ведущих экспертов - специалистов в области доклинических исследований, представителей фармацевтических компаний и регуляторных органов об актуальных вопросах доклинических исследований и фармацевтической разработки лекарственных средств.
Akcionernoe obshchestvo «Nauchno-proizvodstvennoe ob"edinenie «DOM FARMACII»
Title: KONSUL'TANT GLP-PLANET 2023. MNENIE FARMACEVTIChESKOJ OTRASLI
Description:
В монографии «Консультант GLP-PLANET.
Мнение фармацевтической отрасли» приводятся представления ведущих экспертов - специалистов в области доклинических исследований, представителей фармацевтических компаний и регуляторных органов об актуальных вопросах доклинических исследований и фармацевтической разработки лекарственных средств.
Related Results
Renal vasodilation induced by Glucagon‐like peptide‐1 is mediated only by the known receptor
Renal vasodilation induced by Glucagon‐like peptide‐1 is mediated only by the known receptor
Glucagon‐like peptide‐1 (GLP‐1) stimulates insulin release after a meal. The GLP‐1 receptor is found in many tissues including the renal vasculature. GLP‐1 increases renal blood fl...
Weight Loss-Independent Effect of Liraglutide on Insulin Sensitivity in Individuals with Obesity and Pre-Diabetes
Weight Loss-Independent Effect of Liraglutide on Insulin Sensitivity in Individuals with Obesity and Pre-Diabetes
<p dir="ltr">Metabolic effects of glucagon-like peptide-1 (GLP-1) receptor agonists are confounded by weight loss and not fully recapitulated by increasing endogenous GLP-1. ...
Abstract WP109: Glucagon-Like Peptide-1 Has Anti-Inflammatory Effects Through Increasing IB1, A Scaffold Regulator Of JNK, In Cerebral Ischemia
Abstract WP109: Glucagon-Like Peptide-1 Has Anti-Inflammatory Effects Through Increasing IB1, A Scaffold Regulator Of JNK, In Cerebral Ischemia
Background and Purpose:
Hyperglycemia is frequently observed in patients with acute ischemic stroke, and conversely, diabetic patients showed a high frequency of stroke...
Abstract 95: Glucagon Like Peptide-1 (GLP-1) Does Not Cause Vasodilation Even When Dipeptidyl Peptidase 4 (DPP4) is Inhibited
Abstract 95: Glucagon Like Peptide-1 (GLP-1) Does Not Cause Vasodilation Even When Dipeptidyl Peptidase 4 (DPP4) is Inhibited
Glucagon-like peptide 1 (GLP-1) causes direct vasodilation in animal models. Dipeptidyl peptidase 4 (DPP4) inhibitors improve glycemic control in diabetic patients by preventing th...
Diabetes-Associated Common Genetic Variation and Its Association With GLP-1 Concentrations and Response to Exogenous GLP-1
Diabetes-Associated Common Genetic Variation and Its Association With GLP-1 Concentrations and Response to Exogenous GLP-1
The mechanisms by which common genetic variation predisposes to type 2 diabetes remain unclear. The disease-associated variants in TCF7L2 (rs7903146) and WFS1 (rs10010131) have bee...
Evaluation of Strategies for Decreasing Blood Glucose Using Albuminbinding Domain
Evaluation of Strategies for Decreasing Blood Glucose Using Albuminbinding Domain
Objective:Frequent administrations for DPPIV-resistant GLP-1 analogs are necessary to maintain the blood concentrations due to the short half-life of less than 5 minutes. However, ...
Oral GLP-1 Analogue Ameliorates Obesity-Induced Diabetes In Db/Db Mouse
Oral GLP-1 Analogue Ameliorates Obesity-Induced Diabetes In Db/Db Mouse
Abstract
Type 2 diabetes is currently experiencing an outbreak worldwide. GLP-1 effectively lowers blood glucose level as an emerging target for the treatment of type 2 dia...
An endogenous GLP-1 circuit engages VTA GABA neurons to regulate mesolimbic dopamine neurons and attenuate cocaine seeking
An endogenous GLP-1 circuit engages VTA GABA neurons to regulate mesolimbic dopamine neurons and attenuate cocaine seeking
AbstractRecent studies show that systemic administration of a glucagon-like peptide-1 receptor (GLP-1R) agonist is sufficient to attenuate the reinstatement of cocaine-seeking beha...